• Bookmarks

    Bookmarks

  • Concepts

    Concepts

  • Activity

    Activity

  • Courses

    Courses


Bench-to-bedside refers to the process of translating laboratory research findings into clinical applications to improve patient care. This approach aims to bridge the gap between scientific discovery and practical treatment by fostering collaboration between researchers and clinicians.
Clinical trials are research studies performed on human participants to evaluate the safety, efficacy, and optimal use of medical interventions, such as drugs, devices, or treatment protocols. They are conducted in phases, each with specific goals, to ensure that the intervention is both effective and safe for widespread use.
Biomedical research is a broad field of science that seeks to understand biological processes and diseases to develop new treatments and medical technologies. It encompasses both basic research for knowledge discovery and applied research for practical applications in healthcare and medicine.
Patient-centered outcomes focus on what is most important to patients regarding their health and treatment, emphasizing the quality of life and functional status rather than just clinical measures. This approach ensures that healthcare decisions align with patients' preferences, needs, and values, ultimately leading to more personalized and effective care.
Translational Medicine is an interdisciplinary field that aims to bridge the gap between laboratory research and clinical application, ensuring that scientific discoveries lead to tangible health outcomes. It involves a collaborative effort among researchers, clinicians, and industry to accelerate the development of new therapies, diagnostics, and medical procedures.
Implementation Science is the study of methods and strategies to promote the adoption and integration of evidence-based practices, interventions, and policies into routine health and social care settings. It bridges the gap between research and practice, ensuring that scientific discoveries are effectively and efficiently translated into real-world applications.
Healthcare policy refers to the decisions, plans, and actions undertaken to achieve specific healthcare goals within a society, encompassing the creation, implementation, and evaluation of laws, regulations, and guidelines. It aims to improve access to healthcare, enhance quality, and manage costs, balancing the needs of patients, providers, and payers in a dynamic and complex environment.
Animal testing involves the use of non-human animals in experiments and research to assess the safety and efficacy of products or to study biological processes. It is a controversial practice due to ethical concerns over animal welfare and the debate over its necessity and effectiveness in predicting human outcomes.
Biomarker validation is a critical process in ensuring that a biomarker is accurately and reliably associated with a clinical outcome or biological condition. It involves rigorous testing and analysis to confirm the biomarker's specificity, sensitivity, and reproducibility across different populations and settings.
Biological relevance refers to the significance or importance of a biological finding or observation in the context of living organisms and their systems. It emphasizes the practical implications or potential impact on understanding, diagnosing, or treating biological processes and diseases.
Clinical relevance refers to the significance of a study's findings in a real-world healthcare setting, determining whether the results can meaningfully impact patient care and decision-making. It emphasizes the practical application of research outcomes, beyond statistical significance, to ensure they contribute to improved health outcomes and patient wellbeing.
Oncologic research focuses on understanding the mechanisms of cancer development, progression, and treatment to improve patient outcomes. It involves interdisciplinary approaches, including molecular biology, genomics, and clinical trials, to discover and develop new therapies and diagnostic tools.
Therapeutic potential refers to the capacity of a substance, intervention, or approach to provide beneficial effects in treating or managing a disease or condition. It is a critical consideration in the development and evaluation of new medical treatments, encompassing efficacy, safety, and applicability to specific patient populations.
Preclinical studies are a crucial phase in the drug development process where potential therapeutic compounds are tested in vitro and in vivo to evaluate their safety, efficacy, and pharmacokinetics before progressing to human trials. These studies provide foundational data that help determine whether a drug candidate is viable for clinical trials, ultimately guiding the decision-making process for further development.
Biological markers, or biomarkers, are measurable indicators of biological states or conditions, often used in clinical research and medicine to diagnose diseases, predict treatment responses, and monitor health. They can be molecules, genes, or characteristics that provide objective data about physiological processes, offering insights into disease mechanisms and therapeutic targets.
Genomic biomarkers are DNA or RNA characteristics that indicate normal biological processes, pathogenic processes, or responses to therapeutic interventions, providing vital insights for personalized medicine. They enable the identification of disease predispositions, prognosis, and treatment responses, significantly advancing precision healthcare and drug development.
A diagnostic biomarker is a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abNormal process, or of a condition or disease. They are crucial in the early detection, diagnosis, and monitoring of diseases, enabling personalized treatment strategies.
The research-practice gap refers to the disconnect between academic research findings and their application in real-world practice, often due to differences in priorities, language, and timelines between researchers and practitioners. Bridging this gap is essential to ensure that evidence-based knowledge effectively informs decision-making and improves outcomes in various fields.
Scientific advancements are breakthroughs in research and technology that drive progress and innovation across various fields, improving quality of life and expanding human knowledge. These advancements often result from interdisciplinary collaboration, rigorous experimentation, and the application of scientific methods to solve complex problems.
Model organisms are non-human species that are extensively studied to understand biological processes, often serving as a proxy for human biology due to their genetic, physiological, or developmental similarities. They are crucial in research because they allow scientists to explore complex systems in a simplified and controlled environment, facilitating discoveries that can be applied across various fields of biology and medicine.
Medical research is a systematic process aimed at advancing knowledge in the field of medicine to improve patient care, treatment outcomes, and public health. It encompasses a wide range of studies, from basic biological research to clinical trials and epidemiological studies, all contributing to evidence-based medicine.
Therapeutic innovation refers to the development and implementation of new treatments and technologies that significantly improve patient care and outcomes. It encompasses advancements in pharmaceuticals, medical devices, and personalized medicine, driven by research, technology, and interdisciplinary collaboration.
Concept
Biobanking is the process of collecting, storing, and managing biological samples for research purposes, which facilitates advancements in personalized medicine and disease understanding. It plays a crucial role in enabling researchers to access high-quality samples linked with comprehensive data, driving discoveries in genomics, epidemiology, and translational research.
3